Transplantační medicína

Se presentan los resultados de un metaanálisis de 32 estudios del mundo real que evalúan la efectividad e impacto de nirsevimab (Beyfortus) durante la temporada 2023-2024 del virus respiratorio sincicial (VRS). Los estudios fueron realizados en 5 países: España (18 estudios), Francia (8 estudios), Estados Unidos (4 estudios), Italia (1 estudio) y Luxemburgo (1 estudio).​

Parent's experiences of stage 3 diagnosis of T1D.

Parent's experiences of stage 3 diagnosis of T1D.

Parent's experiences of stage 3 diagnosis of T1D.

Parent's experiences of stage 3 diagnosis of T1D.

Parent's experiences of stage 3 diagnosis of T1D.

Breakthrough T1D

Sheba Medical Center, Israel

During the BR1DGE Symposium at the FIP 2025 titled “Shifting the Paradigm: Innovations in T1D Screening and Pharmacist-Led Management”, experts discussed the progression and staging and challenges of autoimmune Type 1 Diabetes, as well as the role of pharmacists as a vital member in the interprofessional care team involved in early detection within community pharmacy settings.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform